Now in its fourth year, Pharma Sustainability Integrates brings together experts, leaders, academics and policy makers from across industry and healthcare to discuss the challenges and opportunities related to reducing the environmental impact of the industry and the wider healthcare system. Featuring keynote presentations, fireside chats and interactive debate-led panel sessions, the agenda will cover policy, strategy, innovation and how industry can play its part in reducing its own Carbon footprint and that of the wider healthcare eco-system.
This year we will discuss:
Aligning long-term environmental goals with cutting-edge innovations like AI and automation to benefit patients and pharma operations.
How to deliver both environmental and business value at every stage of development, manufacturing, and distribution – from circular economy principles to industry partnerships.
The role of sustainability data in driving decarbonisation and reporting – how do you make it work for you?
What does it take to align cutting-edge innovation with long-term environmental goals? This conversation brings together leaders at the intersections of automation, AI and sustainability to examine the risks, responsibilities, and opportunities in leveraging emerging technologies to benefit the industry and ultimately patients too.
GSK
Head of Sustainability & Ecodesign, Medicine Development & Industrialisation
Experienced Vice President with a demonstrated history of working in the pharmaceuticals industry. Strong research, industrialisation and operational professional, skilled in the global leadership of Technical Transfer, Verification and Validation (V&V), Change Control, CMC, GMP, Product Lifecycle Management and Commercial Manufacturing. Responsibilities include, API (Internal & External), Secondary Antibiotic manufacture (Sterile, Oral Solid Dose, Sachets and Suspensions), Materials Science, Biological and Genetic Engineering, Chemical Synthesis, Process & Cleaning Validation and Data & Informatics.
IntelligenceQ
Co-founder & CEO
At IntelligenceQ, I am committed to advancing the future of sustainable medicine manufacturing through AI-driven solutions. Our platform, GyaniMed™ is designed to integrate and simplify complex scientific data across research, process design, and validation, breaking down traditional barriers in medicine manufacturing.
We believe AI is not magic—it is a powerful tool that, when deployed at the right stages, can transform efficiency and collaboration in medicine development. Through real-time AI and Scientist-in-the-Loop technology, GyaniMed™ enables operational and innovation efficiency, providing scientists with sophisticated yet accessible tools to make a meaningful impact. Our goal is to optimise drug manufacturing timelines, enhance sustainability, and empower scientists to bring effective treatments to patients faster.
I am passionate about ensuring that cutting-edge AI technology meets the needs of pharmaceutical scientists and manufacturers by creating accessible, integrated, and cost-friendly solutions that foster collaboration and drive positive change.
Decarbonising supply chains demands deep collaboration, especially in pharma where sustainability now drives KPIs, compliance, risk, and long-term value. From green formulation and packaging to energy-efficient facilities, sustainability is no longer a side project – it’s a competitive differentiator. And in areas such as respiratory care, the opportunity to align clinical outcomes with environmental responsibility is particularly strong. How can companies design environmental responsibility into every stage of development, manufacturing, and distribution?
DHL Supply Chain UKI
VP Business Development & Account Management, Life Sciences & Healthcare
Richard Dunn is a seasoned logistics professional with over 24 years of experience in the supply chain industry and further into Life Sciences and healthcare within the supply chain. Throughout his career, he has demonstrated an unwavering drive for progress and a strong commitment to helping customers and colleagues succeed. Richard’s expertise lies in transforming supply chains through strategic partnerships and innovative solutions.
Richard has been instrumental in the development and deployment of global supply chain solutions for both new and existing customers. His deep understanding of sales strategy and his passion for continuous improvement have led to the successful implementation of innovative approaches that deliver enhanced value to customers.
In addition to his accomplishments in supply chain management, Richard has also been actively involved in the development of sales and account management processes. He has played a key role in the creation of digital tools and resources that have streamlined operations and enhanced overall customer experience.
Can pharma move beyond transactional approaches to sustainability and embrace deeper, innovation-focused partnerships? This session explores how the industry can rethink engagement – shifting from compliance to collaboration – and what it can learn from other sectors that are leading the way in sustainable innovation.
RoslinCT
Head of Sustainability
Adam started his professional career as a chemist, later diversifying into environmental protection focusing on waste management, producer responsibility, and transfrontier shipments of waste. Adam then spent 10 years in consultancy, advising private and public sector clients on strategic and technical application of resource efficiency and the circular economy, before developing and leading corporate sustainability strategies focused on delivering real impact for people and the planet. Adam is an alumnus of the University of Edinburgh and an active member of numerous local, national and global sustainability working groups. He has presented at various conferences and events including COP26, providing global representation for his employers. Adam is a Chartered Waste Manager and accredited Project Manager, a keen cyclist, a father of two boys, and lives in Portobello in Edinburgh.
UCL & Real Zero
Professor Intensive Care Medicine & Co-founder
Intensive Care clinician. Director UCL Centre for Human Health and Performance, with >550 papers (8 in Nature, inc first description of a ‘gene for human performance’.)
Extensive work in Climate Change. Founder https://realzero.earth/
Consults in medtech (inc previously for Google Health/ Deepmind) and pharma (lately vaccines).
Board, Silver Creek Ltd
ex-Board Chair ed-tech: Obrizum https://www.obrizum.com/
5 charity boards
22 years leader in health and climate change (chair 27-country Lancet Countdown)
Founder and Board, ‘Real Zero Ltd’ (non-profit action on climate change)
Award winning author (2 x childrens’ books, 1 x thriller) and script editor.
Public speaker (>600 invited lectures to public, business, medicine and science) fronting >6 TV shows, inc 5 Royal Institution Xmas Lectures 2007)- https://londonspeakerbureau.com/speaker-profile/hugh-montgomery/
As sustainability data becomes more complex, pharma and policy leaders face a new challenge to turn carbon metrics into actionable, impactful decisions. How do we cut through the noise, use data wisely, and apply the right metrics to drive real-world decarbonisation across operations and supply chains and as a basis for reporting?
Sustainable Healthcare Coalition
Chair
As a leading expert in sustainability and health, I currently serve as Chair of the Sustainable Healthcare Coalition a pioneering organisation that brings together partners to advance sustainable healthcare.
Additionally, I act as an independent expert advisor and board member for various national and global organisations, providing valuable insight and guidance on well-being and sustainability.
I’m passionate about reframing thinking and have a track record of developing innovative strategies and programmes at the heart of business and government.
My background includes senior roles in the UK Government as Deputy Chief Medical Officer and Director General, in the World Health Organisation as Director of Chronic Disease and Health Promotion, and in the private sector, as Bupa’s Chief Wellbeing Officer and as a Director in PwC’s health and sustainability teams.
I am a visiting Professor at UCL and a Senior Associate at Cambridge Institute for Sustainability Leadership and have served on various boards including British Land’s Sustainability Advisory Panel, Marks and Spencer’s Sustainable Retail Advisory Board, and Business in the Community’s Wellbeing Leadership Team.
Medicines and Healthcare products Regulatory Agency (MHRA)
Head of Standards and Regulatory Governance, Secretary, Scientific Director of the BP Commission
Steve Hoare is responsible for the British Pharmacopoeia, which sets the minimum standards for Quality for medicines marketed in the UK (and recognised in over 100 countries) , and is supporting the MHRA in the development of its Sustainability Policy. An analytical chemist by training, Steve has a background in Quality roles in the pharmaceutical industry, most recently a policy director for a biopharmaceutical trade association, leading on both regulation and sustainability. Steve is active in the development of international approaches to sustainability in standards setting.
Bayer
Head of Sustainability & Public Affairs UK & Ireland
Andy spent 17 years in senior Sales leadership and Commercial roles within FMCG, Skincare and Pharma, he then made a career pivot over 3 years ago to proactively supercharge and lead the Sustainability agenda at Bayer UK & Ireland. Andy works across the full spectrum of Sustainability, covering Policy, ESG & Non-Financial Disclosures, Carbon Footprinting, Impact Valuation, Life Cycle Assessments, Employee Engagement and many more.
Andy voices how driving a culture of sustainability and incorporating it into everyday roles and responsibilities is essential to delivering a net zero agenda as well as the powerful role story telling plays in supporting organisations transformation from Board level all the way through the business.
GSK
Director, Global Sustainability Policy
Rachel leads GSK’s global approach to environmental sustainability policy, supporting the company’s ambition for a net zero, nature positive, healthier planet. Rachel has worked in policy and government affairs roles across the pharmaceutical sector for over 10 years, and has previously worked on environmental policy, including in the European parliament and in the water sector.
The promise of circularity is clear, but how can pharma make it a powerful driver of transformation and growth? Panellists will discuss practical strategies to embed circular economy principles across pharma operations, reduce waste, and create sustainable, regenerative systems that deliver long-term environmental and business benefits – while still keeping the patient front of mind.
Sartorius
Sustainability Marketing Expert
Lara Cobacho Lluesma has been working for Sartorius since 2022, where she currently serves as Sustainability Marketing Expert. She holds a Master’s degree in Life Science Economy and Policy with a focus on sustainability from the Technical University of Munich.
She initially joined Sartorius as a Sustainability Project Manager, leading strategic partnerships and acting as the key liaison for sustainability initiatives with major biopharma customers. In 2024, she transitioned into her current role, where she drives strategic marketing communications and industry advocacy for sustainable bioprocessing. Her work emphasizes the importance of advancing the sustainability of Single-Use Technologies (SUTs), which are increasingly recognized in biomanufacturing not only for their operational benefits, but also for their potential to reduce environmental impact. Her work focuses on initiatives that enhance process efficiency, promote circularity, and facilitate industry collaboration. These efforts are recognized as crucial to leverage the environmental advantages of SUTs within the biopharma industry.
More details coming soon!
